Advanced Filters
noise
Found 64,783 clinical trials
J Juan Celi de la Torre, MD

Biomarkers in Prediction of AMI

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

18 years of age All Phase N/A
H Huji Xu, Doctor

A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases

The purpose of this study is to determine the safety, tolerability and preliminary efficacy of NEUK203-215 , a healthy donor (HD) allogeneic CD19/BCMA-targeted CAR-NK cell product, in participants with severe, refractory autoimmune diseases.

18 - 65 years of age All Phase N/A

A Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy

Laparoscopic radical prostatectomy (LRP) is the main treatment method for early prostate cancer, and postoperative urinary incontinence is one of the main complications after LRP. Urologists have applied various new operations in clinical practice to improve the urinary incontinence of patients after LRP surgery, but urinary incontinence is still the …

- 79 years of age Male Phase N/A
G Gang An

A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma

This is a prospective Phase II study evaluating Siltuximab for CRS and ICANS after CAR-T infusion in multiple myeloma patients.

18 years of age All Phase 2
E Emilie Miley

Does Psychoeducation Improve the Pain Relief Derived From a Brief Intervention

This project is a single-site, five-arm, randomized controlled trial investigating whether providing patients in an orthopedic clinic waiting room psychoeducation about mindfulness impacts the degree of pain relief they experience during a mindfulness-based intervention.

18 years of age All Phase N/A

Urinary Creatinine Excretion Time in the Neonatal Period

Newborn's renal function is difficult to assess and its physiology during the first days of life is still incompletely known. Studies suggest that the newborn almost completely reabsorbs creatinine during the first 48 to 72 hours of life, while at the same time it continues to produce its own creatinine. …

- 3 years of age All Phase N/A
A Alex Armstrong

Dual Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

Large vessel vasculitis is a disease that causes damage to blood vessels. This damage to blood vessels can increase the risk of patients with LVV developing cardiovascular disease, including heart attacks and strokes. A chemical produced in the body called endothelin may contribute to this increase in cardiovascular disease risk …

18 years of age All Phase 2
P Philippe RIGOARD, MD, PhD

Dynamic Measurement of Cerebrospinal Fluid in Healthy Subjects: Pilot Study

This research will enhance our knowledge and understanding of Cerebrospinal Fluid (CSF) circulation around the Central Nervous System (CNS) (brain and spinal cord). The main objective is to obtain flow velocities using Phase Contrast (PC) MRI over the entire subarachnoid space (SAS). This will enable us to develop and validate …

18 years of age All Phase N/A
D Dr Muhammad Ali Sheikh

Early vs Conventional Enteral Nutrition After Uncomplicated Paediatric Open Appendectomy

This clinical trial is conducted to see if after surgery of appendix(open appendectomy) in children giving oral nutrition within 6hours of surgery instead of older method of starting oral nutrition after 24hours of surgery improves the outcome or not which is the length of hospital stay(from the day of surgery …

6 - 14 years of age All Phase N/A

Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

A phase I, open-label clinical study to evaluate the safety, tolerability, and efficacy of LUCAR-E9D,LUCAR-E9K, a dual-targeted cell preparation targeting CD19/CD20, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.

18 - 75 years of age All Phase N/A

Simplify language using AI